Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-04-26Clinical Trial Update: Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) [Phase 4]
Phase 4 clinical trial REVISE-Diab obesity randomises Endobarrier alone versus Endobarrier plus an incretin analogue in people with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients [Phase 1]
Phase 1 clinical trial evaluating tolerability of HS-20004 with titration administration in adults with Type 2 diabetes.
-
CLINICAL_TRIALS research · 2016-04-25Clinical Trial Update: Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy
A completed observational study investigated correlations between genetic profiles and phenotypic features in type 2 diabetic retinopathy.
-
CLINICAL_TRIALS withdrawal · 2016-04-25Clinical Trial Update: GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
The Bayer-sponsored clinical trial GLucobay M evaluating safety and effectiveness in adults with type 2 diabetes not well controlled on mono…
-
FDA approval · 2016-04-22FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for liraglutide filed by Teva Pharmaceuticals USA, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion [Phase 1]
This Phase 1 clinical trial update investigates feed-back suppression of meal-induced GLP-1 secretion in people with Type 2 diabetes. The st…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell [NA]
The completed trial evaluated the effects of the diabetes drug dapagliflozin on incretin sensitivity of pancreatic beta cells in adults with…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia [NA]
A completed clinical trial assessing the effect of gemigliptin on metabolic endotoxemia and lipemia in individuals with type 2 diabetes mell…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification [Phase 3]
Phase 3 trial evaluating insulin degludec in combination with liraglutide and metformin in Type 2 diabetes patients eligible for treatment i…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Activator and Type II Diabetics
The document notes that a clinical trial testing Activator in individuals with Type 2 diabetes mellitus has completed. No efficacy or safety…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Glycemic Durability After Metformin Failure [Phase 4]
This entry references a Phase 4 clinical trial evaluating glycemic durability after metformin failure in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease [Phase 4]
Phase 4 trial evaluating the effect of the vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in…
-
CLINICAL_TRIALS safety_alert · 2016-04-19Clinical Trial Update: Incretin-based Drugs and the Risk of Heart Failure
A CNODES observational study update examines whether incretin-based therapies for type 2 diabetes influence the risk of heart failure.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of adding gemigliptin 50 mg once daily to glimepiride and metformin in patients with…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes [NA]
This completed clinical trial evaluated whether adding a nutritional intervention to an exercise program benefits adults with Type 2 Diabete…
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Spanish Diabetes Self-Management Program [NA]
A completed clinical trial evaluating a Spanish diabetes self-management program for adults with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes [Phase 1]
This Phase 1 safety and pharmacokinetics study of a new drug for type 2 diabetes in healthy volunteers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing the combination of empagliflozin and linagliptin versus linagliptin alone over 24 weeks in adults with Type 2 diabet…
-
CLINICAL_TRIALS research · 2016-04-18Clinical Trial Update: Effect of Diabetes Mellitus on Cholesterol Metabolism [NA]
Clinical trial update examining the effect of diabetes mellitus on cholesterol metabolism; completed with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-04-18Clinical Trial Update: Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes
This clinical trial update investigates the role of endoplasmic reticulum stress in the pathophysiology of type 2 diabetes.
-
CLINICAL_TRIALS research · 2016-04-18Clinical Trial Update: G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)
A clinical trial update on the G-CREDIT study, a Yonsei University‑led cohort program evaluating risk factors for type 2 diabetes and impair…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: User Evaluation of the MiniMed 620G and 640G Insulin Pumps [NA]
A completed clinical trial evaluating user experience with the MiniMed 620G and 640G insulin pumps has posted results.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) [Phase 3]
Phase 3 results update for sitagliptin cardiovascular outcomes study (MK-0431-082) in type 2 diabetes mellitus; trial completed with results…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Effect of Exenatide on Liver and Heart Fat and Inflammation [Phase 4]
Phase 4 clinical trial evaluating the effect of Exenatide on liver and heart fat and inflammation in type 2 diabetes; results were posted in…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
A completed Takeda-sponsored trial evaluates the long-term use of Sonias Combination Tablets in adults with type 2 diabetes mellitus. Result…